Your browser doesn't support javascript.
Akt-Fas to Quell Aberrant T Cell Differentiation and Apoptosis in Covid-19.
Leonardi, Anthony J; Proenca, Rui B.
  • Leonardi AJ; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Proenca RB; Department of Biology, Johns Hopkins University, Baltimore, MD, United States.
Front Immunol ; 11: 600405, 2020.
Article in English | MEDLINE | ID: covidwho-1013339
ABSTRACT
Aberrant T cell differentiation and lymphopenia are hallmarks of severe COVID-19 disease. Since T cells must race to cull infected cells, they are quick to differentiate and achieve cytotoxic function. With this responsiveness, comes hastened apoptosis, due to a coupled mechanism of death and differentiation in both CD4+ and CD8+ lymphocytes via CD95 (Fas) and serine-threonine kinase (Akt). T cell lymphopenia in severe cases may represent cell death or peripheral migration. These facets depict SARS-Cov-2 as a lympho-manipulative pathogen; it distorts T cell function, numbers, and death, and creates a dysfunctional immune response. Whether preservation of T cells, prevention of their aberrant differentiation, and expansion of their population may alter disease course is unknown. Its investigation requires experimental interrogation of the linked differentiation and death pathway by agents known to uncouple T cell proliferation and differentiation in both CD4+ and CD8+ T cells.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / Cell Differentiation / Apoptosis / CD8-Positive T-Lymphocytes / Fas Receptor / Proto-Oncogene Proteins c-akt / SARS-CoV-2 / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Front Immunol Year: 2020 Document Type: Article Affiliation country: Fimmu.2020.600405

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / Cell Differentiation / Apoptosis / CD8-Positive T-Lymphocytes / Fas Receptor / Proto-Oncogene Proteins c-akt / SARS-CoV-2 / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Front Immunol Year: 2020 Document Type: Article Affiliation country: Fimmu.2020.600405